Bo Kruse - Net Worth and Insider Trading
Bo Kruse Net Worth
The estimated net worth of Bo Kruse is at least $3 Million dollars as of 2024-11-29. Bo Kruse is the EVP, CFO, SECRY & TREAS. of Y-mAbs Therapeutics Inc and owns about 210,877 shares of Y-mAbs Therapeutics Inc (YMAB) stock worth over $3 Million. Details can be seen in Bo Kruse's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Bo Kruse has not made any transactions after 2024-05-31 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Bo Kruse
Bo Kruse Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Bo Kruse owns 1 companies in total, including Y-mAbs Therapeutics Inc (YMAB) .
Click here to see the complete history of Bo Kruse’s form 4 insider trades.
Insider Ownership Summary of Bo Kruse
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
YMAB | Y-mAbs Therapeutics Inc | 2024-05-31 | director & EVP & CFO & Secy & Treas. |
Bo Kruse Latest Holdings Summary
Bo Kruse currently owns a total of 1 stock. Bo Kruse owns 210,877 shares of Y-mAbs Therapeutics Inc (YMAB) as of May 31, 2024, with a value of $3 Million.
Latest Holdings of Bo Kruse
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
YMAB | Y-mAbs Therapeutics Inc | 2024-05-31 | 210,877 | 11.88 | 2,505,219 |
Holding Weightings of Bo Kruse
Bo Kruse Form 4 Trading Tracker
According to the SEC Form 4 filings, Bo Kruse has made a total of 19 transactions in Y-mAbs Therapeutics Inc (YMAB) over the past 5 years, including 0 buys and 19 sells. The most-recent trade in Y-mAbs Therapeutics Inc is the sale of 60,000 shares on May 31, 2024, which brought Bo Kruse around $723,000.
Insider Trading History of Bo Kruse
- 1
Bo Kruse Trading Performance
Bo Kruse Ownership Network
Bo Kruse Owned Company Details
What does Y-mAbs Therapeutics Inc do?
Who are the key executives at Y-mAbs Therapeutics Inc?
Bo Kruse is the director & EVP & CFO & Secy & Treas. of Y-mAbs Therapeutics Inc. Other key executives at Y-mAbs Therapeutics Inc include director & President and Chairman Thomas Gad , Sr. VP and Head of Tech Op Torben Lund-hansen , and Sr. VP and COO Joris Wilms .
Y-mAbs Therapeutics Inc (YMAB) Insider Trades Summary
Over the past 18 months, Bo Kruse made 1 insider transaction in Y-mAbs Therapeutics Inc (YMAB) with a net sale of 60,000. Other recent insider transactions involving Y-mAbs Therapeutics Inc (YMAB) include a net sale of 501,251 shares made by Thomas Gad , a net purchase of 279,028 shares made by Johan Wedell-wedellsborg , and a net purchase of 279,028 shares made by Biotech Aps Wg .
In summary, during the past 3 months, insiders sold 95,000 shares of Y-mAbs Therapeutics Inc (YMAB) in total and bought 0 shares, with a net sale of 95,000 shares. During the past 18 months, 620,366 shares of Y-mAbs Therapeutics Inc (YMAB) were sold and 558,056 shares were bought by its insiders, resulting in a net sale of 62,310 shares.
Y-mAbs Therapeutics Inc (YMAB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Y-mAbs Therapeutics Inc Insider Transactions
Bo Kruse Mailing Address
Above is the net worth, insider trading, and ownership report for Bo Kruse. You might contact Bo Kruse via mailing address: C/o Y-mabs Therapeutics, Inc., 230 Park Avenue, 33rd Floor, New York Ny 10169.